Home NDC 55513-180 BKEMV
Product NDC 55513-180
11-digit product format 555130180
Labeler code 55513
Product ID 55513-180_20150720-3435-4d6c-8eb1-55e6bc56cdce
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name eculizumab-aeeb
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler Amgen Inc
Application BLA761333
Marketing category BLA
Marketing start 2025-03-01
Substance ECULIZUMAB
Active strength 300 mg/30mL
Pharmacologic classes Complement Inhibitor [EPC], Complement Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base BKEMV
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ECULIZUMAB 300 mg/30mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination A3ULP0F556 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2706351 Internal RxNorm lookup 2706358 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55513-180-01 BKEMV 30 mL in 1 VIAL INJECTION, SOLUTION, CONCENTRATE 30 7 55513-180-01 BKEMV 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55513-180 BKEMV (ECULIZUMAB-AEEB) INJECTION, SOLUTION, CONCENTRATE [AMGEN INC] 5 Current NDC, 2 package rows 20250302_002f9748-b0e8-4b6e-a38b-56930a839491.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join BKEMV ECULIZUMAB-AEEB Amgen Inc 002f9748-b0e8-4b6e-a38b-56930a839491 2026-07-02 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761333 ndc (product): 55513-180
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761333 Bkemv eculizumab-aeeb 351(k) Interchangeable Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 55513-180-01 55513018001 1 VIAL in 1 CARTON (55513-180-01) / 30 mL in 1 VIAL 1 vial 2025-03-01 No No Current